Ignite Creation Date:
2024-05-06 @ 7:17 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05955391
Status:
RECRUITING
Last Update Posted:
2023-07-21
First Post:
2023-07-10
Brief Title:
TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer NSCLC
Sponsor:
Shenzhen TargetRx Inc
Organization:
Shenzhen TargetRx Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-01-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-08-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-10
First Submit QC Date:
July 18 2023
Study First Post Date:
2023-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-18
Last Update Post Date:
2023-07-21
Last Update Post Date Type:
ACTUAL